LETTER
One-Pot Synthesis of a-Alkylidene-g-butyrolacton-2-ones
1857
(11) (a) Moise, J.; Arseniyadis, S.; Cossy, J. Org. Lett. 2007, 9,
1695. (b) Raju, R.; Allen, L.; Le, T.; Taylor, C.; Howell, A.
Org. Lett. 2007, 9, 1699. (c) Oh, S.; Jeong, I. H.; Shin, W.
S.; Wang, Q.; Lee, S. Bioorg. Med. Chem. Lett. 2006, 16,
1656.
(12) (a) Janecki, T.; Blaszczyk, E.; Janecka, A.; Krajewaska, U.;
Rozalski, M. J. Med. Chem. 2005, 48, 3516. (b) Huang,
W. C.; Chan, S. T.; Yang, T. L.; Tzeng, C. C.; Chen, C. C.
Carcinogenesis 2004, 25, 1925.
(13) (a) De Bernardi, M.; Garlaschelli, L.; Toma, L.; Vidari, G.;
Vita-Finzi, P. Tetrahedron 1991, 47, 7109. (b) Vidari, G.;
Lanfranchi, G.; Pazzi, N.; Serra, S. Tetrahedron Lett. 1999,
40, 3063. (c) Jung, M.; Lee, S.; Yoon, B. Tetrahedron Lett.
1997, 38, 2871. (d) Tesaki, S.; Kikuzaki, H.; Yonemori, S.;
Nakatani, N. J. Nat. Prod. 2001, 64, 515.
(14) (a) De, D.; Seth, M.; Bhaduri, A. P. Synthesis 1990, 956.
(b) Ohta, T.; Miyake, T.; Seido, N.; Kumobayashi, H.;
Takaya, H. J. Org. Chem. 1995, 60, 357. (c) Arcadi, A.;
Chiarini, M.; Marinelli, F.; Berente, Z.; Kollàr, L. Org. Lett.
2000, 2, 69.
(15) Otto, A.; Liebscher, J. Synthesis 2003, 1209.
(16) Gasperi, T.; Loreto, M. A.; Tardella, P. A.; Veri, E.
Tetrahedron Lett. 2003, 44, 4953.
(17) (a) Castulík, J.; Marek, J.; Mazal, C. Tetrahedron 2001, 57,
8339. (b) Otto, A.; Ziemer, B.; Liebscher, J. Synthesis 1999,
965.
(18) (a) Otto, A.; Ziemer, B.; Liebscher, J. Eur. J. Org. Chem.
1998, 2667. (b) Otto, A.; Abegaz, B.; Ziemer, B.; Liebscher,
J. Tetrahedron: Asymmetry 1999, 10, 3381. (c) Nishimura,
K.; Tomioka, K. J. Org. Chem. 2002, 67, 431.
(19) Read de Alaniz, J.; Rovis, T. J. Am. Chem. Soc. 2005, 127,
6284.
(20) (a) Neelakantan, S.; Seshadri, T. R. Current Sci. (India)
1959, 28, 476. (b) Haynes, L. J.; Plimmer, J. R. Quart. Rev.
1960, 14, 292. (c) Brodersen, R.; Kjaer, A. Acta Pharmacol.
Toxicol. 1946, 2, 109.
(21) (a) Effenberger, F.; Syed, J. Tetrahedron: Asymmetry 1998,
9, 817. (b) Bühler, H.; Bayer, A.; Effenberger, F. Chem. Eur.
J. 2000, 6, 2564.
(22) Kasettrathat, C.; Ngamrojanavanich, N.; Wiyakrutta, S.;
Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Phytochemistry
2008, 69, 2621.
(23) (a) Schobert, R.; Schlenk, A. Bioorg. Med. Chem. 2008, 16,
4203. (b) Pevet, I.; Meyer, C.; Cossy, J. Tetrahedron Lett.
2001, 42, 5215. (c) Bourdreux, Y.; Bodio, E.; Willis, C.;
Billaud, C.; Gall, T.; Mioskowski, C. Tetrahedron 2008, 64,
8930. (d) Mitsos, C. A.; Zografos, A. L.; Igglessi-
Markopoulou, O. J. Org. Chem. 2000, 65, 5852.
(e) Sodeoka, M.; Sampe, R.; Kojima, S.; Baba, Y.; Usui, T.;
Ueda, K.; Osada, H. J. Med. Chem. 2001, 44, 3216.
(f) Peukert, S.; Sun, Y.; Zhang, R.; Hurley, B.; Sabio, M.;
Shen, X.; Gray, C.; Dzink-Fox, J.; Tao, J.; Cebula, R.;
Wattanasin, S. Bioorg. Med. Chem. Lett. 2008, 18, 1840.
(g) Schobert, R.; Urbina-Gonzalez, J. M. Tetrahedron Lett.
2005, 46, 3657.
(24) (a) Ramachandran, P.; Garner, G.; Pratihar, D. J. Org. Lett.
2007, 9, 4753. (b) Moïse, J.; Arseniyadis, S.; Cossy, J. Org.
Lett. 2007, 9, 1695. (c) Seitz, M.; Reiser, O. Curr. Opin.
Chem. Biol. 2005, 9, 285. (d) Yavari, I.; Hossaini, Z.
Tetrahedron Lett. 2006, 47, 4465. (e) Zhang, Q.; Lu, X.;
Han, X. J. Org. Chem. 2001, 66, 7676. (f) Kitson, R. R. A.;
Taylor, R. J. K.; Wood, J. L. Org. Lett. 2009, 11, 5338.
(g) Ramachandran, P. V.; Pratiharorg, D. Org. Lett. 2007, 9,
2087. (h) Moise, J.; Arseniyadis, S.; Cossy, J. Org. Lett.
2007, 9, 1695. (i) Ramachandran, P. V.; Garner, G.;
Pratihar, D. Org. Lett. 2007, 9, 4753.
(25) (a) Alizadeh, A.; Movahedi, F.; Esmaili, A. A. Tetrahedron
Lett. 2006, 47, 4469. (b) Alizadeh, A.; Movahedi, F.;
Masrour, H.; Zhu, L. G. Synthesis 2006, 3431. (c)Alizadeh,
A.; Rezvanian, A.; Zhu, L. G. Tetrahedron 2008, 64, 351.
(d) Alizadeh, A.; Rezvanian, A.; Bijanzadeh, H. R. Synthesis
2008, 725. (e) Alizadeh, A.; Babaki, M.; Zohreh, N.
Tetrahedron 2009, 65, 1704. (f) Alizadeh, A.; Babaki, M.;
Zohreh, N. Synthesis 2008, 3295.
(26) To a magnetically stirred 10 mL flat-bottom flask,
containing ethylamine (0.09 g, 2 mmol) was added methyl
acetoacetate (0.24 g, 2 mmol), and this mixture was stirred
at r.t. under solvent-free conditions for 10 min. A solution of
chloroacetyl chloride (0.22 g, 2 mmol) in MeCN (5 mL) was
added dropwise to the reaction mixture. The progress of the
reaction was followed by TLC. When enaminone 5 was fully
consumed, MeOH (2 mL) was added and the mixture
allowed to stir at 110–120 °C for 11 h. After completion of
the reaction, the solvent was removed under reduced
pressure. The residue was purified by column chromatog-
raphy on silica gel (n-hexane–EtOAc = 1:1) to obtain
product 4a as a white powder (0.12 g, 71%). IR (KBr): 3460
(NH), 1728 (CO2), 1638 (C=O), 1615 (C=C) cm–1. MS (EI,
70 eV): m/z (%) = 169 (93) [M+], 151 (85), 123 (38), 95 (34),
82 (69), 68 (50), 58 (100), 42 (92).
E-Isomer of 4a: 1H NMR (500.13 MHz, CDCl3): d = 1.35 (3
H, t, 3JH,H = 7.3 Hz, CH2CH3), 2.54 (3 H, s, CH3), 3.47 (2 H,
q, 3JH,H = 7.3 Hz, CH2CH3), 4.40 (2 H, s, CH2O), 10.99 (1 H,
s, NH). 13C NMR (125.75 MHz, CDCl3): d = 13.86
(CH2CH3), 14.42 (CH3), 38.43 (CH2CH3), 69.97 (OCH2),
91.76 (C=CCH3), 170.80 (C=CCH3), 172.52 (CO2), 197.10
(C=O).
Z-isomer of 4a: 1H NMR (500.13 MHz, CDCl3): d = 1.32 (3
H, t, 3JH,H = 7.3 Hz, CH2CH3), 2.58 (3 H, s, CH3), 3.50 (2 H,
q, 3JH,H = 7.3 Hz, CH2CH3), 4.38 (2 H, s, CH2O), 10.01 (1 H,
s, NH). 13C NMR (125.75 MHz, CDCl3): d = 14.27
(CH2CH3), 14.62 (CH3), 38.12 (CH2CH3), 72.00 (OCH2),
90.36 (C=CCH3), 169.94 (C=CCH3), 176.35 (CO2), 193.62
(C=O).
Compound 4b: yield 0.28 g (80%); white powder; mp 112–
114 °C. IR (KBr): 3465 (NH), 1734 (CO2), 1661 (C=O),
1604 (C=C) cm–1. MS (EI, 70 eV): m/z (%) = 183 (100)
[M+], 165 (87), 154 (70), 150 (59), 137 (39), 125 (47), 97
(75), 82 (72), 67 (70).
E-isomer of 4b: 1H NMR (500.13 MHz, CDCl3): d = 1.05 (3
H, t, 3JH,H = 7.4 Hz, CH2CH3), 1.75 (2 H, q, 3JH,H = 7.4 Hz,
CH2CH3), 2.55 (3 H, s, CH3), 3.43 (2 H, t, 3JH,H = 6.9 Hz,
CH2N), 4.42 (2 H, s, OCH2), 11.10 (1 H, s, NH). 13C NMR
(125.75 MHz, CDCl3): d = 11.16 (CH2CH3), 13.96 (CH3),
30.87 (CH2CH3), 45.18 (CH2N), 69.97 (CH2O), 91.88
(C=CCH3), 161.90 (C=CCH3), 170.96 (CO2), 197.18 (C=O).
Z-isomer of 4b: 1H NMR (500.13 MHz, CDCl3): d = 1.03 (3
H, t, 3JH,H = 7.4 Hz, CH2CH3), 1.72 (2 H, q, 3JH,H = 7.4 Hz,
CH2CH3), 2.60 (3 H, s, CH3), 3.40 (2 H, t, 3JH,H = 7.0 Hz,
CH2N), 4.40 (2 H, s, OCH2), 10.13 (1 H, s, NH). 13C NMR
(125.75 MHz, CDCl3): d = 11.16 (CH2CH3), 14.37 (CH3),
31.22 (CH2CH3), 44.85 (CH2N), 72.04 (CH2O), 90.44
(C=CCH3), 161.93 (C=CCH3), 170.07 (CO2), 193.61 (C=O).
Compound 4e: yield 0.28 g (82%); white powder; mp 118–
120 °C. IR (KBr): 3230 (NH), 1725 (CO2), 1639 (C=O),
1604 (C=C) cm–1. MS (EI, 70 eV): m/z (%) = 183 (100)
[M+], 165 (78), 137 (24), 110 (39), 96 (94), 83 (47), 67 (35),
55 (16).
E-isomer of 4e: 1H NMR (500.13 MHz, CDCl3): d = 1.30 (6
H, d, 3JH,H = 6.2 Hz, 2 CHCH3), 2.51 (3 H, s, CH3), 3.91–
3.99 (1 H, m, 1 CHCH3), 4.33 (2 H, s, CH2O), 10.94 (1 H, s,
NH). 13C NMR (125.75 MHz, CDCl3): d = 13.85 (2
CHCH3), 22.82 (CH3), 45.75 (CHCH3), 69.89 (CH2O),
Synlett 2010, No. 12, 1854–1858 © Thieme Stuttgart · New York